Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm
- PMID: 32958687
- DOI: 10.4049/jimmunol.2000892
Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which rapidly became a pandemic of global proportions. Sepsis is commonly present with high lethality in the severe forms of the disease. The virus-induced cytokine storm puts the immune system in overdrive at the expense of the pathogen-specific immune response and is likely to underlie the most advanced COVID-19 clinical features, including sepsis-related multiple organ dysfunction as well as the pathophysiological changes found in the lungs. We review the major therapeutic strategies that have been considered for sepsis and might be amenable to repurposing for COVID-19. We also discuss two different immunization strategies that have the potential to confer antiviral heterologous protection: innate-induced trained immunity and adaptive-induced immune response resetting.
Copyright © 2020 by The American Association of Immunologists, Inc.
Similar articles
-
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020. Front Immunol. 2020. PMID: 32849623 Free PMC article. Review.
-
The Management of Cytokine Storm in COVID-19.Acta Med Indones. 2020 Jul;52(3):306-313. Acta Med Indones. 2020. PMID: 33020343 Review.
-
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.Neuroscientist. 2020 Oct-Dec;26(5-6):402-414. doi: 10.1177/1073858420941476. Epub 2020 Jul 18. Neuroscientist. 2020. PMID: 32684080 Review.
-
Lymphopenia in COVID-19: Therapeutic opportunities.Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3. Cell Biol Int. 2020. PMID: 32458561 Free PMC article. Review.
-
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).J Biomed Sci. 2020 Jun 4;27(1):72. doi: 10.1186/s12929-020-00663-w. J Biomed Sci. 2020. PMID: 32498686 Free PMC article. Review.
Cited by
-
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.Front Immunol. 2023 Jun 14;14:1133225. doi: 10.3389/fimmu.2023.1133225. eCollection 2023. Front Immunol. 2023. PMID: 37388738 Free PMC article. Review.
-
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses.Brain. 2023 Oct 3;146(10):4292-4305. doi: 10.1093/brain/awad155. Brain. 2023. PMID: 37161609 Free PMC article.
-
Network modeling-based identification of the switching targets between pyroptosis and secondary pyroptosis.Chaos Solitons Fractals. 2022 Feb;155:111724. doi: 10.1016/j.chaos.2021.111724. Epub 2022 Jan 2. Chaos Solitons Fractals. 2022. PMID: 36570873 Free PMC article.
-
Plasmacytoid dendritic cells during COVID-19: Ally or adversary?Cell Rep. 2022 Jul 26;40(4):111148. doi: 10.1016/j.celrep.2022.111148. Epub 2022 Jul 14. Cell Rep. 2022. PMID: 35858624 Free PMC article. Review.
-
Immune-Mediated Mechanisms of COVID-19 Neuropathology.Front Neurol. 2022 May 19;13:882905. doi: 10.3389/fneur.2022.882905. eCollection 2022. Front Neurol. 2022. PMID: 35665037 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous